Categories AlphaGraphs, Earnings, Finance

Charles Schwab (SCHW) Q3 earnings top expectations; revenues up 20%

Financial services company The Charles Schwab Corporation (NYSE: SCHW) on Monday reported higher earnings and revenues for the third quarter of 2022. The results also exceeded Wall Street’s forecast.

Charles Schwab Q3 2022 earnings infographic

Total revenues increased 20% year-over-year to $5.50 billion in the third quarter of fiscal 2022. The number also came in above Wall Street’s estimates.

Net profit, on an adjusted basis, moved up to $1.10 per share in the three-month period from $0.84 per share in the comparable quarter of last year. Unadjusted net income was $2.02 billion or $0.99 per share, compared to $1.53 billion or $0.74 per share in the year-ago quarter. Analysts had predicted slower growth.

Check this space to read management/analysts’ comments on Charles Schwab’s Q3 2022 results

“Schwab’s performance during the third quarter reflected the continued success of our “Through Clients’ Eyes” strategy and our contemporary full-service approach to helping clients achieve their financial goals. As we assisted investors with navigating persistent macroeconomic headwinds, we continued to drive robust business growth. Bolstered by record third quarter retail inflows, core net new assets equaled $115 billion for the period – a 7% annualized growth rate,” said Walt Bettinger, CEO of Charles Schwab.

Prior Performance

  • The Charles Schwab Corporation Q2 2022 Earnings Infographic
  • The Charles Schwab Corporation Q1 2022 earnings infographic
  • The Charles Schwab Corporation Q4 2021 earnings infographic
  • The Charles Schwab Corporation Q3 2021 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel

TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including advanced allogeneic chimeric antigen receptor (CAR) T-cell therapy products for

Cintas Corp. (CTAS) Q3 2023 earnings and revenue increase

Uniform rental company Cintas Corporation (NASDAQ: CTAS) on Wednesday announced financial results for the third quarter of 2023, reporting higher earnings and revenues. At $2.19 billion, third-quarter revenues were up

Infographic: Micron (MU) reports net loss for Q2; revenue down 53%

Micron Technology Inc. (NASDAQ: MU) slipped to a loss in the second quarter of 2023 from a profit last year, hurt by a sharp fall in revenues. The chipmaker reported

Add Comment
Viewing Highlight